In making selections for Super Doctors, MSP Communications employs a rigorous multi-step process designed to identify healthcare providers who have attained a high degree of peer recognition and professional achievement. Super Doctors is a selective yet diverse listing of outstanding doctors, representing consumer-oriented medical specialties.
FDA Approves First Drug for Treatment of Peanut Allergy for Children
The U.S. Food and Drug Administration approved Palforzia to mitigate allergic reactions that may occur with accidental exposure to peanuts.
FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease
The U.S. Food and Drug Administration today cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer’s disease. The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in adult patients, aged 55 years and older, exhibiting signs and symptoms of the disease.
Sleep joins revamped list of heart health essentials
Sleep duration has joined the seven original metrics to measure ideal cardiovascular health, now called Life's Essential 8.
Researchers discover biomarker for tracking depression recovery
New deep brain stimulation device coupled with powerful AI may improve therapy for treatment-resistant depression.
Super Doctors identifies top doctors as selected by their peers and the independent research of MSP Communications. Please note: Doctors cannot pay to be included on Super Doctors® listings nor are they paid to provide input.
Super Doctors is published online and also in print as a special advertising section in leading newspapers and city and regional magazines.
Super Doctors appears in top city and regional publications around the U.S.: